1144 related articles for article (PubMed ID: 24579874)
1. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
[TBL] [Abstract][Full Text] [Related]
3. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
Ong J; Younossi ZM
Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
[TBL] [Abstract][Full Text] [Related]
5. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical associations of posttransplant fatty liver disease.
Lim LG; Cheng CL; Wee A; Lim SG; Lee YM; Sutedja DS; Da Costa M; Prabhakaran K; Wai CT
Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.
Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.
Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P
Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008
[TBL] [Abstract][Full Text] [Related]
13. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
14. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
16. A population-based study on the prevalence of NASH using scores validated against liver histology.
Hyysalo J; Männistö VT; Zhou Y; Arola J; Kärjä V; Leivonen M; Juuti A; Jaser N; Lallukka S; Käkelä P; Venesmaa S; Simonen M; Saltevo J; Moilanen L; Korpi-Hyövalti E; Keinänen-Kiukaanniemi S; Oksa H; Orho-Melander M; Valenti L; Fargion S; Pihlajamäki J; Peltonen M; Yki-Järvinen H
J Hepatol; 2014 Apr; 60(4):839-46. PubMed ID: 24333862
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
[TBL] [Abstract][Full Text] [Related]
19. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
20. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.
Villeret F; Dharancy S; Erard D; Abergel A; Barbier L; Besch C; Boillot O; Boudjema K; Coilly A; Conti F; Corpechot C; Duvoux C; Faitot F; Faure S; Francoz C; Giostra E; Gugenheim J; Hardwigsen J; Hilleret MN; Hiriart JB; Houssel-Debry P; Kamar N; Lassailly G; Latournerie M; Pageaux GP; Samuel D; Vanlemmens C; Saliba F; Dumortier J
JHEP Rep; 2023 Mar; 5(3):100668. PubMed ID: 36852108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
